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Abstract
Increasing evidence suggests that the source of dietary protein can have an impact on weight gain and fat mass during high-fat feeding in
both humans and rodents. The present study examined whether dietary bovine serum albumin (BSA) as the dominant source of protein
alters energy balance and adiposity associated with high-fat feeding. C57/BL6J mice were given a diet with 10 % of energy from fat and 20 %
of energy from casein or a diet with 45 % of energy from fat and either 20 % of energy from casein (HFD) or BSA (HFDþBSA) for 13 weeks.
The HFDþBSA diet did not significantly alter daily energy expenditure, locomotor activity and RER, but did increase cumulative energy
intake and percentage of lean mass while reducing feed efficiency and percentage of fat mass when compared with the HFD (P,0·05).
In subcutaneous adipose tissue (SAT), the HFDþBSA diet increased the mRNA levels of PPARa (PPARA), carnitine palmitoyltransferase 1b
(CPT1b) and uncoupling protein 3 (UCP3), but reduced the mRNA level of leptin when compared with the HFD (P,0·05). The SAT mRNA
levels of PPARA, CPT1b and UCP3 were negatively correlated (P,0·05) with SAT mass, which was reduced in HFDþBSA mice compared
with HFD controls (P,0·01). No differences in epididymal fat mass existed between the groups. The HFDþBSA diet normalised plasma
leptin and corticosterone levels compared with the HFD (P,0·05). While differences in leptin levels were associated with the percentage of
fat mass (P,0·01), changes in corticosterone concentrations were independent of the percentage of fat mass (P,0·05). The data
suggest that the HFDþBSA diet influences plasma leptin levels via SAT mass reduction where mRNA levels of genes linked to b-oxidation
were increased, whereas differences in plasma corticosterone levels were not related to fat mass reduction.
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Energy balance is in part controlled by a complex interplay
involving hypothalamic expression of neuropeptides and per-
ipheral hormones, such as leptin (LEP) and glucocorticoids
(corticosterone in rodents and cortisol in humans)(1,2). A dys-
regulation of energy balance-related mechanisms leads to a
sustained positive energy balance and build-up of energy
reserves in the form of TAG, which is first deposited in adi-
pose tissues and then ectopically in other tissues, resulting
in the obese phenotype(3). As obesity has become an
ever-increasing health concern due to its prevalence and
associated clinical conditions, such as non-alcoholic fatty
liver disease and type 2 diabetes mellitus, efforts to identify
dietary solutions for this plight have intensified.
One area of research that has shown promise in the manage-
ment of obesity through increased satiety and lipid metabolism
inhumans andmice involvesmodulationof the source of dietary
protein, for example the use of dietary whey protein isolate
(WPI), as well as its component proteins, such as lactoferrin,
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a-lactalbumin, glycomacropeptide and b-lactoglobulin(4–7).
For instance, intake of enteric-coated lactoferrin reduces
body weight and visceral fat mass in humans compared
with intake of placebo tablets(8). Similarly, obese mice
after a period of energy restriction with a diet containing
lactoferrin have been reported to show reduced fat mass
compared with energy-restricted mice fed WPI(9). Similar
data have been obtained from energy-restricted mice fed
a-lactalbumin(9).
The present study focused on bovine serum albumin (BSA),
which is a whey-associated protein. Albumin is a plasma pro-
tein involved in maintaining homeostatic colloidal pressure
and also acts as a carrier protein for fatty acids, catecholamines
and other hormones(10,11). To the best of our knowledge, no
previous studies have examined the effect of orally adminis-
tered BSA as the primary source of dietary protein on
energy balance or lipid accretion associated with diet-induced
obesity; therefore, it is not known whether dietary BSA, similar
to other whey proteins, could be used as a food ingredient to
impede the development of obesity. Because of the lack of
knowledge regarding dietary BSA, the present study focused
on energy balance and hypothalamic mRNA levels in male
C57/BL6J mice over a 13-week period similar to previous
studies involving WPI(5,12). Likewise, it was unknown whether
there would be an impact of dietary BSA on lipid accretion, so
subcutaneous and epididymal fat pads were collected from
the aforementioned mice and examined for alterations in the
mRNA levels of genes involved in lipid catabolism and anabo-
lism, taking into account that a previous study involving diet-
ary WPI, of which BSA is a component, showed a differential
impact on subcutaneous and epididymal adipose tissues (EAT)
following a 14-week high-fat dietary challenge(12).
Materials and methods
Animals and diets
The use and care of animals adhered to the licence obtained
under the Cruelty to Animals Act 1876, and associated work
received approval from the University College Cork Animal
Ethics Committee (no. 2011/005). Mice had ad libitum
access to fresh water and one of the following three diets
(Research Diets, Inc.): low-fat diet (LFD) (10 % of energy
from fat and 20 % of energy from casein; D12450B); HFD
(45 % of energy from fat and 20 % of energy from casein;
D12451); HFDþBSA (D1201180), in which casein in the
HFD was replaced with 20 % of energy from BSA (Sigma-
Aldrich). Further details of the diets, which are all open
source, can be found in online Supplementary Table S1 and
were obtained from Research Diets, Inc. The diets comprised
20 % dietary protein, because it fell within a normal physio-
logical range (14–25 %) and was similar to the energy content
found in previous studies involving dietary WPI(5,6).
Experimental protocol
Male C57/BL6J mice (Harlan), aged 3–4 weeks, were group-
housed in individually ventilated cages maintained at a 12 h
light–12 h dark cycle, 20–228C and 45–65 % humidity, and
fed a LFD during the initial 5-week acclimatisation period.
At 8 weeks of age, mice were switched to either the HFD or
HFDþBSA diet, or maintained on the LFD (n 8) for a period
of 13 weeks. Body weight and food intake were measured
weekly. Energy intake (EI, in kJ) was calculated based on
the energy content of the diets (high fat 1·022 kJ/g; low fat
0·92 kJ/g) multiplied by food intake (in g). Feed efficiency
(body mass gain (g)/energy intake (MJ))(13) was calculated
for the first 8 weeks of the trial before mice were placed in
metabolism cages. During weeks 9–12, mice were individu-
ally housed in the TSE PhenoMastere System (TSE Systems)
for 72 h. After the initial 48 h acclimatisation period, metabolic
parameters were measured during the final 24 h period. CO2
production (VCO2) and oxygen consumption (VO2) were
measured using indirect open-circuit calorimetry. These data
allowed the calculation of the RER ( ¼ VCO2/VO2). Locomotor
activity was determined using a multi-dimensional IR beam
system that measured the number of breaks along the X, Y
and Z axes. All sensors recorded data for each mouse during
a 60 s period at 9 min cycles. In week 12, faecal pellets were
collected and stored at 2208C. In week 13, after a 4–6 h
fast, body composition was determined using a Bruker Minis-
pec LF50H analyser (Bruker Optics). Mice were anaesthetised
(65 mg/kg ketamine and 13 mg/kg xylazine), and blood was
collected into Vacutainer EDTA tubes (Becton, Dickinson and
Company) before being mixed with 500 000 KUI/l (17·5 mg/ml
plasma) of aprotinin (Sigma-Aldrich) and 0·1 mM-diprotin A
(Sigma-Aldrich) to protect hormones from proteolytic degra-
dation. Mice were euthanised by cervical dislocation, and
brain, posterior subcutaneous adipose tissue (SAT) and EAT
were harvested, weighed and snap-frozen in liquid N2 or dry
ice (brain) before being stored at 2808C until analysis.
Gene expression
Total RNA was extracted from hypothalamic blocks and from
the adipose tissue using the RNeasy Lipid Tissue Mini Kit
(Qiagen). As a precaution against potential genomic DNA
contamination, RNA was treated with RNase-Free DNase
(Qiagen). RNA purity was determined by NanoDrop
(Thermo Scientific), and all samples had 260/280 readings
between 1·9 and 2·1. For the synthesis of complementary
DNA, 1mg of total RNA was used in transcription reactions
containing 2·5 ng/ml of random hexamer primers (Bioline),
0·5 mM-deoxyribonucleic triphosphate (Promega), 2 U/ml of
RNase inhibitor (Promega), and Superscript II (Life Technol-
ogies). Then, complementary DNA was amplified using the
SYBR Green Select Master Mix (Life Technologies) with
0·25mM-primers (MWG Operons) and 1ml complementary
DNA. Primer sequences are detailed in online Supplementary
Table S2. DNA amplification was performed in a LightCycler
480 Real-Time PCR system (Roche) under the following con-
ditions: 10 min at 958C, fifty cycles of 958C for 10 s, 55–608C
for 5 s, and 728C for 15 s. The authenticity of PCR products
was verified by melting curve analysis and sequencing
(MWG Operons). In instances where two or more housekeep-
ing genes were used, their geometric mean was determined
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for normalisation(14). The following reference genes were
used: RNA, 18S ribosomal 1 (RNA18S) and b-actin (ACTB)
for both subcutaneous and EAT, and RNA18S and tyrosine
3-mono-oxygenase/tryptophan 5-mono-oxygenase activation
protein, zeta polypeptide (YWHAZ) for the hypothalamus.
Gene expression was determined using the DDCT method
relative to the LFD control group, and data were averaged
per group(15).
Hormones and faecal fat
Plasma samples were measured in duplicate for the concen-
trations of corticosterone (catalogue no. ADI-900-097; Enzo
Life Sciences), insulin (catalogue no. 90 080; Crystal Chem),
glucose (catalogue no. 65 333; Abcam), NEFA (catalogue no.
ab65341; Abcam) and LEP (catalogue no. 100-130-LEM; Alpha
Diagnostics), according to the manufacturers’ instructions. The
percentage of faecal fat was determined in duplicate using
a modified version of the Folch method based on previous
published studies(16,17). Distilled water was added to thawed
pellets (10 ml to 1 g) and allowed to rest at room temperature
overnight. Then, chloroform and methanol in 2:1 (v/v) and
0·58 % (w/v) aqueous NaCl solutions were mixed with samples
before centrifugation. The chloroform phase was transferred to
fresh pre-weighed tubes and measured before evaporation.
Finally, weights of the tubes were measured again to determine
total lipid content in faecal mass.
Statistical analysis
Statistical comparisons of groups were performed using
ANOVA in conjunction with a Tukey post hoc test with Prism
(GraphPad Software, Inc.) and Minitab (Minitab, Inc.). VO2,
plasma LEP and corticosterone data were analysed by
ANCOVA (SAS software, version 9.3) using total body weight
or percentage of fat mass as the covariant, as detailed pre-
viously(18). Residual checks were made to ensure that the
assumptions of the analysis (e.g. normality and constant
variance) were met. Significance was established at P,0·05.
Data are presented as means with their standard errors.
Results
Dietary bovine serum albumin suppressed feed efficiency,
weight gain and percentage of fat mass
Both body weight and weight gain were significantly
increased in the HFD group compared with the LFD and
HFDþBSA groups (Fig. 1(a) and 1(b)). Similarly, the LFD
and HFDþBSA groups had a significantly higher percentage
of lean mass and a correspondingly lower percentage of fat
mass than the HFD group (Fig. 1(c)). During weeks 9–12,
metabolic activity data showed that the HFDþBSA group
exhibited significantly increased EI compared with the LFD
group with no significant differences between the other two
groups (Table 1) . However, over time, (cumulative) EI was
greater in the HFDþBSA and HFD groups when compared
with the LFD group, and was higher in the HFDþBSA
group compared with the HFD group at week 8 (Fig. 1(d)).
To examine this further, hypothalamic mRNA levels of genes
associated with energy balance regulation were studied, and
showed a significant increase in the hypothalamic mRNA
levels of PPARa (PPARA) in both the HFD and HFDþBSA
groups compared with the LFD group (P,0·05; see online
Supplementary Fig. S1(F)) with no change in the mRNA
levels of other genes associated with energy balance
regulation, specifically pro-opiomelanocortin (POMC), LEP
receptor (OB-r) or neuropeptide Y (NPY) (see online
Supplementary Fig. S1(A)–(C)). No changes in locomotor
activity and water intake were found between the groups
(Table 1), and the variation in the RER between HFD-fed
mice and LFD-fed mice followed expected patterns for
utilisation of dietary fat as the main energy source (Table 1).
The analysis of VO2 data by ANCOVA, with body mass as
the covariate, showed that the diets had no significant
impact on this parameter (Table 1), with the variation in
body weight associated with changes in VO2 (see online
Supplementary Fig. S2). Faecal fat content in the HFDþBSA
and LFD groups was significantly less than that in the HFD
group (Table 1), and feed efficiency for the LFD and
HFDþBSA groups was significantly less than that for the
HFD group (Fig. 1(e)).
Dietary bovine serum albumin normalised plasma leptin
and corticosterone levels
Circulating LEP concentration was significantly higher in the
HFD group than in the LFD group; however, LEP levels
were normalised in the HFDþBSA group (Fig. 2(a)). There
was a correlation between LEP level and percentage of fat
mass (r 0·79, P,0·0001; Fig. 2(b)); however, when the percen-
tage of fat mass was used as a covariate in ANCOVA, no differ-
ences were found in LEP level between the groups
(normalised data: 4·73 (SE 1·68) for the LFD group, 9·12
(SE 1·44) for the HFD group and 6·33 (SE 1·15) for the
HFDþBSA group), indicating that the effects observed for
plasma LEP level were due to alterations in the percentage
of fat mass, rather than to the dietary influence on LEP
secretion. Plasma corticosterone levels were also normalised
in the HFDþBSA group compared with the HFD group
(Fig. 2(c)). In contrast to the dietary effect on LEP levels,
when the strong correlation between percentage of fat mass
and plasma corticosterone levels (r 0·72, P,0·05; Fig. 2(d))
was further explored using ANCOVA with fat mass as a covari-
ate, a significant difference was observed between the LFD
and HFD groups (P,0·05) and between the HFDþBSA and
HFD groups (P,0·01) (normalised data: 139·65 (SE 36·02)
for the LFD group, 299·03 (SE 38·05) for the HFD group and
100·33 (SE 28·17) for the HFDþBSA group). This indicates
that reduced circulating corticosterone levels in the
HFDþBSA group were not due to the reduced percentage
of fat mass of this group, but rather to a direct effect of the
diet on additional mechanisms involved. Hypothalamic
mRNA levels of genes implicated in the production of cortico-
sterone, namely corticotropin-releasing hormone (CRH) and
arginine vasopressin receptor 1a (V1a), were not significantly
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altered when compared with the HFD group (see online
Supplementary Fig. S1(D) and (E))
Fasting plasma insulin levels in the HFDþBSA group were
significantly increased compared with the LFD group (Table 1),
while fasting plasma glucose levels remained unchanged
between all the groups, and fasting NEFA levels were only
significantly altered between the LFDandHFD groups (Table 1).
Dietary bovine serum albumin reduced subcutaneous fat
mass and altered related gene expression
The present analysis showed that posterior SAT (inguinal fat
pad) was significantly increased by HFD feeding and reduced
by HFDþBSA intake (Table 1). Investigation of genes associ-
ated with b-oxidation revealed that SAT mRNA expression
levels of PPARA had a strong inverse relationship with SAT
mass (r 20·75, P,0·0001), so it was intriguing that
HFDþBSA mice had elevated mRNA levels of PPARA in SAT
compared with HFD mice (Fig. 3(a)). Similar negative associ-
ations between mRNA levels and SAT mass were observed for
other genes involved in b-oxidation, namely carnitine palmi-
toyltransferase 1b (CPT1b) (r 20·76, P,0·001) and uncou-
pling protein 3 (UCP3)(19) (r 20·69, P,0·001), both of
which were significantly increased in the SAT of the
HFDþBSA group when compared with the HFD group
(Fig. 3(b) and (c)). The mRNA expression level of LEP in
SAT was significantly reduced in the HFDþBSA and LFD
groups compared with the HFD group (Fig. 3(g)).
There was no significant effect of dietary BSA on high-fat
diet-associated mRNA levels for lipid catabolism-associated
b-adrenergic receptor (b3AR) or lipid anabolism-associated
lipoprotein lipase (LPL), fatty acid synthase (FASN),
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Fig. 1. Effect of dietary bovine serum albumin (BSA) on physiological parameters in C57/BL6J mice fed a high-fat diet. Data are shown for (a) body weight,
(b) weight gain, (c) body composition over a period of 13 weeks, (d) cumulative energy intake (EI, kJ) up to week 8 and (e) feed efficiency for the first 8 weeks
before mice were placed in metabolism cages. Values are means (n 8), with standard errors represented by vertical bars. Mean value was significantly different
from that of the LFD group: *P,0·05, **P,0·01. Mean value was significantly different from that of the HFD group: †P,0·05, ††P,0·01. LFD ((a) and
(b)–(e) ), 10 % of energy from the fat diet with 20 % of energy from casein; HFD ((a) and (b)–(e) ), 45 % of energy from the fat diet with 20 % of energy
from casein; HFD þ BSA ((a) and (b)–(e) ), 45 % of energy from the fat diet with 20 % of energy from BSA.
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glucocorticoid receptor (GCCR) or 11b-hydroxysteroid dehy-
drogenase type 1 (HSD11b1) in SAT (Fig. 3(d)– (f), (h) and
(i)). There was also no significant alteration in the SAT
mRNA levels of the adipogenic transcription factor PPARG
(1·00 (SE 0·09) for the LFD group, 0·88 (SE 0·09) for the HFD
group and 0·91 (SE 0·14) for the HFDþBSA group).
Dietary bovine serum albumin moderately affected
epididymal fat mass and related gene expression
The EAT of the HFDþBSA group was not significantly altered
when compared with either of the control groups; however,
an increased trend was observed in the HFD group compared
with the LFD group after normalisation to body weight
(P¼0·06; Table 1). While there was no difference between
the groups in the mRNA levels of PPARA or UCP3 in EAT
(Fig. 4(a) and (c)), the mRNA levels of CPT1b showed
increased trends in the HFDþBSA group relative to the LFD
(P¼0·094) and HFD (P¼0·061) groups (Fig. 4(b)).
There were no significant high fat-related differences in the
EAT mRNA levels of b3AR (Fig. 4(d)), FASN (Fig. 4(f)), LEP
(Fig. 4(g)), HSD11b1 (Fig. 4(i)) or PPARG (1·00 (SE 0·24) for
the LFD group, 1·06 (SE 0·21) for the HFD group and 1·31
(SE 0·30) for the HFDþBSA group); however, when compared
with the LFD group, the HFDþBSA group showed strong
increased trends in the mRNA levels of LPL (P¼0·054;
Fig. 4(e)) and GCCR (P¼0·054; Fig. 4(h)). There were also
increased mRNA levels of fatty acid translocator (FAT/CD36)
in the HFDþBSA group when compared with the LFD
group (P,0·05) (1·00 (SE 0·29) for the LFD group, 3·83 (SE
0·61) for the HFD group and 4·99 (SE 1·34) for the
HFDþBSA group). Consistent with the impact of glucocorti-
coids on EAT tissue lipid metabolism(20), a strong association
was observed when EAT mRNA levels of GCCR and LPL
were compared (r 0·88, P,0·001).
Discussion
The key finding of the present study was that dietary BSA
specifically reduced SAT weight and plasma LEP and cortico-
sterone levels, despite mice having a significantly higher
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(a) plasma leptin level, (b) the correlation between leptin levels and percen-
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Table 1. Assessment of metabolic parameters over 24 h, hormones and metabolites, and adipose tissue mass in C57/BL6J mice fed dietary bovine
serum albumin (BSA) in conjunction with a high-fat diet
(Mean values with their standard errors; n 8)
LFD HFD HFD þ BSA
Mean SE Mean SE Mean SE
Energy intake‡ (kJ) 35·37 2·94 41·11 3·91 54·42* 6·84
Water intake‡ (ml) 2·50 0·24 1·95 0·15 2·67 0·39
VO2‡ (ml/min) 1·65 0·03 1·86 0·07 1·78 0·06
Locomotor activity‡ (beam breaks) 229·79 9·75 200·12 12·47 197·66 9·89
RER‡ 0·82 0·02 0·75** 0·01 0·75** 0·01
Fasting insulin§ (pmol/l) 5·62 0·10 6·74 0·26 7·89** 0·59
Fasting glucose§ (mmol/l) 10·00 0·62 12·01 1·09 10·2 0·83
QUICKI§ 0·46 0·01 0·435* 0·01 0·439 0·01
Fasting NEFA§ (nmol/ml) 0·19 0·04 0·46* 0·04 0·43 0·07
SAT mass§ (g/100 g body weight) 1·00 0·06 2·38** 0·23 1·44†† 0·25
EAT mass§ (g/100 g body weight) 2·76 0·27 4·28 0·37 3·97 0·61
Percentage of faecal fat§ (relative to the LFD control group) 100 23·65 337·85** 38·03 115·62†† 13·29
LFD, 10 % of energy from a fat diet with 20 % of energy from casein; HFD, 45 % of energy from a fat diet with 20 % of energy from casein; HFD þ BSA, 45 % of energy from a
fat diet with 20 % of energy from BSA; QUICKI, quantitative insulin sensitivity check index; SAT, subcutaneous adipose tissue; EAT, epididymal adipose tissue.
Mean value was significantly different from that of the LFD group: *P,0·05, **P,0·01
Mean value was significantly different from that of the HFD group: ††P,0·01.
‡ Metabolic activity data were collected during weeks 10–12 of a 13-week study using the TSE PhenoMastere System (TSE Systems), at 9 min intervals over a 24 h period.
§ Data were measured from samples collected at week 13 of the study.
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cumulative EI, and unaffected energy expenditure, thereby
indicating that dietary BSA has an effect on lipid metabolism
in high fat-fed mice. This is further suggested by the significant
increase in mRNA levels found in SAT for genes associated
with b-oxidation, specifically PPARA, CPT1B and UCP3.
Mice fed a HFDþBSA diet had similar EI and metabolic
activity during a 24 h period to that of the HFD control
group; however, over time, their cumulative EI became
higher than that for both LFD and HFD groups. Interestingly,
the mRNA expression of PPARA was significantly higher in the
hypothalamus of the HFD and HFDþBSA groups when com-
pared with the LFD group. Recently, it has been shown that
increasing PPARA levels in the brain of mice with inactivated
pancreatic and hypothalamic FASN corrects for hypophagia
found in these mice, and suggests that there is a specific hypo-
thalamic FASN/PPARA sensory pathway that leads to increased
EI(21). Additionally, these FASN-inactivated mice, when given a
high-fat diet, ate significantly less and expended significantly
more energy as defined by VO2 than their wild-type counter-
parts(22), most probably due to a disruption in the FASN/
PPARA signalling pathway. In the present study, whether the
change in cumulative EI represents the activation of the afore-
mentioned pathway or whether the mRNA expression levels
of PPARA simply reflect a secondary consequence of the
high-fat diet ingested by mice(22) remains to be determined.
As hypothalamic mRNA level of other genes associated with
the regulation of energy balance, namely NPY and POMC,
was not different between the groups, an alternate route of
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Fig. 3. Effect of dietary bovine serum albumin (BSA) on subcutaneous gene expression levels in C57/BL6J mice fed a high-fat diet. Housekeeping genes were
b-actin (ACTB) and RNA, 18S ribosomal 1 (RNA18S). The genes examined were (a) PPARA, (b) carnitine palmitoyltransferase 1b (CTP1b), (c) uncoupling
protein 3 (UCP3), (d) b-adrenergic receptor-3 (b3AR), (e) lipoprotein lipase (LPL), (f) fatty acid synthase (FASN), (g) leptin (LEP), (h) glucocorticoid receptor
(GCCR) and 11b-hydroxysteroid dehydrogenase type 1 (HSD11b1). mRNA expression is shown relative to the LFD control group set at 1·00. Values are means
(n 8), with their standard errors represented by vertical bars. Mean value was significantly different from that of the LFD group: *P,0·05, **P,0·01. Mean value
was significantly different from that of the HFD group: †P,0·05, ††P,0·01. LFD ( ), 10 % of energy from a fat diet with 20 % of energy from casein; HFD ( ),
45 % of energy from a fat diet with 20 % of energy from casein; HFD þ BSA ( ), 45 % of energy from a fat diet with 20 % of energy from BSA. SAT, subcutaneous
adipose tissue.
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control appears to be responsible for the increased cumulative
energy but reduced weight gain in the HFDþBSA group.
Feed efficiency, calculated for the first 8 weeks of the trial,
was significantly lower for the HFDþBSA group compared
with the HFD group, indicating that the former group was
less efficient in converting consumed energy into body mass
than the HFD group. These results coincide with a study car-
ried out by Tranberg et al.(12), in which mice fed a high-fat diet
with WPI had reduced feed efficiency when compared with
those fed with casein. To examine this further, faecal fat was
analysed; however, it was found that the percentage of
faecal fat of the HFDþBSA group was significantly less than
that of the HFD group, implying greater intestinal lipid absorp-
tion, something not reflected by percentage of fat mass of this
group. This suggests that BSA influences energy balance by
affecting lipid metabolism in the adipose tissue (see below).
We also speculate that excretion of non-lipid macromolecules
in the faeces (not examined here) and/or energy loss via
urinary output may have reduced lipid content available for
anabolic processes; similarly, urinary excretion of tricarboxylic
acid intermediates is responsible for energy loss associated
with WPI(23).
Fat mass is determined by both adipocyte size and
number(3). As the SAT mRNA levels of the adipogenic tran-
scription factor PPARG were not altered between the high
fat-fed groups, this indicates that altered adipocyte number
is not the main cause of the reduced SAT mass observed in
the HFDþBSA group, but is more likely due to reduced adipo-
cyte size, possibly via increased b-oxidation of lipid stores.
Consistent with this finding, the intake of HFDþBSA increased
the SAT mRNA levels of genes associated with b-oxidation,
namely PPARA, UCP3 and CPT1b. This is important, because
SAT serves as the main buffer for the storage of excess EI, and
when its capacity is exceeded, fat accumulation occurs else-
where throughout the body(24). Thus, the reduction in fat mass
in the HFDþBSA group could be, at least in part, related to
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Fig. 4. Effect of dietary bovine serum albumin (BSA) on epididymal gene expression levels in C57/BL6J mice fed a high-fat diet. Housekeeping genes were
b-actin (ACTB) and RNA, 18S ribosomal 1 (RNA18S). The genes examined were (a) PPARA, (b) carnitine palmitoyltransferase 1b (CTP1b), (c) uncoupling protein
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increased lipid catabolism in SAT, and could explain why mice
fed the HFDþBSA diet had reduced body weight gain, but
increased cumulative EI compared with the HFD group. Also,
as the body’s primary source of LEP, SAT plays an important
role in total plasma LEP concentration, and therefore its pro-
duction is associated with increased fat mass(24). This was
reflected in the present study by the reduced SAT mass, reduced
SAT mRNA levels of the LEP gene and the correspondingly
reduced levels of circulating LEP found in the HFDþBSA
group when compared with the HFD group. Interestingly, the
presumed increased fat catabolism in SAT was not reflected in
the RER or VO2 between the HFDþBSA and HFD groups. It is
feasible that this may be because of the increased energy con-
sumed by the HFDþBSA group being lost through excretion(23)
and b-oxidation in SAT. Consistent with this notion, we
observed (but did not quantify) increased urination in the
HFDþBSA group compared with the other groups, which was
reflected by a higher intake of water in mice; however, this
difference did not reach significance compared with the other
control groups.
In contrast to SAT, visceral adipose tissue has been shown to
be more associated with health complications corresponding
to the obese state, such as type 2 diabetes mellitus and non-
alcoholic fatty liver disease(24). In the present study, the
HFDþBSA group did not show altered EAT mass when com-
pared with either of the control groups, nor were the mRNA
levels of adipogenic or b-oxidation genes changed. However,
there was an increased trend in the mRNA levels of CPT1b in
comparison with the HFD group. A couple of noteworthy obser-
vations were made that indicate potential counter-regulatory
changes (in the gene expression of CPT1b and thus action) in
EAT lipid metabolism with HFDþBSA feeding. First, plasma
insulin levels were increased in the HFDþBSA group compared
with the LFDgroup, consistentwith increased cumulative EI, but
both groups had similar glucose levels, which indicate a higher
tissue uptake of glucose. Second, an increased trend in mRNA
levels existed for GCCR in the HFDþBSA group compared
with the LFD group, despite both groups having similar cortico-
sterone levels. As a strong correlation existed between EAT
mRNA levels of GCCR and LPL, and both showed an increased
trend in the HFDþBSA group compared with the LFD group,
the data may indicate higher corticosterone-induced lipid
uptake in the EAT of the HFDþBSA group(20). This is further
supported by the increased EAT mRNA levels of FAT/CD36 in
the HFDþBSA group compared with the LFD group, and
could help to account for the unaltered EAT mass, despite
having a trend towards increased mRNA levels of CPT1b
when compared with either of the control groups. Further
investigation is required to establish the potential functional
relationship between dietary BSA, corticosterone and EAT
lipid metabolism. Given that female C57/BL6J mice that have
not been ovariectomised show greater resistance to obesity
from high-fat feeding due to hormonal differences when
compared with males, it may be of interest to examine the
effect that dietary BSA has on LEP and corticosterone levels in
a female wild-type model to further elucidate what impact
hormones may or may not have on the results found in the
present study(25).
The synthesis of corticosterone is regulated by the activity of
the hypothalamus–pituitary–adrenal (HPA) axis and by the
peripheral tissues involving HSD11b1(26,27). In the present
study, EAT mRNA levels of HSD11b1 were unresponsive to
the diets, while SAT mRNA levels of HSD11b1 was decreased
in both high fat-fed groups compared with the LFD group.
These findings suggest that it is unlikely that differences
found in plasma corticosterone levels were due to the periph-
eral production of corticosterone. Although the central pro-
duction of corticosterone is influenced by LEP stimulation of
hypothalamic V1a and CRH gene expression(28), in the present
study, neither of these genes showed changes in response to
the HFDþBSA diet, suggesting that LEP and/or associated
hypothalamic signalling was not responsible for the altered
corticosterone concentrations. To assess whether a factor
other than LEP produced in proportion to fat mass may be
responsible for changes in plasma corticosterone levels,
latter data were examined using percentage of fat mass as a
covariate, which indicated that the circulating levels of corti-
costerone found in HFDþBSA mice were not affected by
the change in the percentage of fat mass, but rather were
related to the diet acting through some other mechanism.
Further investigation is required to determine whether intake
of HFDþBSA has an impact on different regions of the HPA
axis, such as the adrenal glands that have been shown to
increase the production of corticosterone in mice given a
high-fat diet due to morphological and functional changes(29),
and how any changes in HPA activity affect peripheral lipid
metabolism through corticosterone action.
In summary, mice fed with HFDþBSA had significantly
higher cumulative EI, but decreased percentage of fat mass,
primarily through a significant decrease in SAT mass when
compared with the HFD control group. SAT mass reduction
was most probably due to an increase in the expression of
genes associated with b-oxidation. While plasma LEP concen-
tration was reduced to LFD levels in the HFDþBSA group,
primarily due to a reduction in the percentage of fat mass,
a significant decrease in plasma corticosterone levels was
not due to either the change in the percentage of fat mass
or associated LEP acting through hypothalamic V1a and CRH
gene expression. Further work is required to better under-
stand the mechanisms underlying the aforementioned
changes, which will help to uncover the components of diet-
ary BSA responsible for these changes and, in turn, to target
negative effects associated with obesity, such as increased
fat mass and corticosterone levels.
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